Cargando…

The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase

BACKGROUND: The involvement of Heat Shock Proteins (HSP) in cancer development and progression is a widely debated topic. The objective of the present study was to evaluate the presence and expression of HSP60 and HSP10 in a series of large bowel carcinomas and locoregional lymph nodes with and with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappello, Francesco, David, Sabrina, Rappa, Francesca, Bucchieri, Fabio, Marasà, Lorenzo, Bartolotta, Tommaso E, Farina, Felicia, Zummo, Giovanni
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1289279/
https://www.ncbi.nlm.nih.gov/pubmed/16253146
http://dx.doi.org/10.1186/1471-2407-5-139
_version_ 1782126181883052032
author Cappello, Francesco
David, Sabrina
Rappa, Francesca
Bucchieri, Fabio
Marasà, Lorenzo
Bartolotta, Tommaso E
Farina, Felicia
Zummo, Giovanni
author_facet Cappello, Francesco
David, Sabrina
Rappa, Francesca
Bucchieri, Fabio
Marasà, Lorenzo
Bartolotta, Tommaso E
Farina, Felicia
Zummo, Giovanni
author_sort Cappello, Francesco
collection PubMed
description BACKGROUND: The involvement of Heat Shock Proteins (HSP) in cancer development and progression is a widely debated topic. The objective of the present study was to evaluate the presence and expression of HSP60 and HSP10 in a series of large bowel carcinomas and locoregional lymph nodes with and without metastases. METHODS: 82 Astler and Coller's stage C2 colorectal cancers, of which 48 well-differentiated and 34 poorly-differentiated, were selected along with 661 lymph nodes, including 372 with metastases and 289 with reactive hyperplasia only, from the same tumours. Primitive tumours and both metastatic and reactive lymph nodes were studied; specifically, three different compartments of the lymph nodes, secondary follicle, paracortex and medullary sinus, were also analysed. An immunohistochemical research for HSP60 and HSP10 was performed and the semiquantitative results were analysed by statistical analysis to determine the correlation between HSPs expression and 1) tumour grading; 2) degree of inflammation; 3) number of lymph nodes involved; 4) lymph node compartment hyperplasia. Moreover, western blotting was performed on a smaller group of samples to confirm the immunohistochemical results. RESULTS: Our data show that the expression of HSP60, in both primary tumour and lymph node metastasis, is correlated with the tumoral grade, while the HSP10 expression is not. Nevertheless, the levels of HSP10 are commonly higher than the levels of HSP60. In addition, statistical analyses do not show any correlation between the degree of inflammation and the immunopositivity for both HSP60 and HSP10. Moreover, we find a significant correlation between the presence of lymph node metastases and the positivity for both HSP60 and HSP10. In particular, metastatic lymph nodes show a higher percentage of cells positive for both HSP60 and HSP10 in the secondary follicles, and for HSP10 in the medullary sinuses, when compared with hyperplastic lymph nodes. CONCLUSION: HSP60 and HSP10 may have diagnostic and prognostic significance in the management of this tumour and their overexpression in tumoral cells may be functionally related to tumoral progression. We hypothesise that their expression in follicular and medullary cells of lymph nodes may be induced by formation of metastases. Further studies based on these observations could lead to a better understanding of the HSPs involvement in colorectal cancer progression, as well as other neoplasms.
format Text
id pubmed-1289279
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12892792005-11-24 The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase Cappello, Francesco David, Sabrina Rappa, Francesca Bucchieri, Fabio Marasà, Lorenzo Bartolotta, Tommaso E Farina, Felicia Zummo, Giovanni BMC Cancer Research Article BACKGROUND: The involvement of Heat Shock Proteins (HSP) in cancer development and progression is a widely debated topic. The objective of the present study was to evaluate the presence and expression of HSP60 and HSP10 in a series of large bowel carcinomas and locoregional lymph nodes with and without metastases. METHODS: 82 Astler and Coller's stage C2 colorectal cancers, of which 48 well-differentiated and 34 poorly-differentiated, were selected along with 661 lymph nodes, including 372 with metastases and 289 with reactive hyperplasia only, from the same tumours. Primitive tumours and both metastatic and reactive lymph nodes were studied; specifically, three different compartments of the lymph nodes, secondary follicle, paracortex and medullary sinus, were also analysed. An immunohistochemical research for HSP60 and HSP10 was performed and the semiquantitative results were analysed by statistical analysis to determine the correlation between HSPs expression and 1) tumour grading; 2) degree of inflammation; 3) number of lymph nodes involved; 4) lymph node compartment hyperplasia. Moreover, western blotting was performed on a smaller group of samples to confirm the immunohistochemical results. RESULTS: Our data show that the expression of HSP60, in both primary tumour and lymph node metastasis, is correlated with the tumoral grade, while the HSP10 expression is not. Nevertheless, the levels of HSP10 are commonly higher than the levels of HSP60. In addition, statistical analyses do not show any correlation between the degree of inflammation and the immunopositivity for both HSP60 and HSP10. Moreover, we find a significant correlation between the presence of lymph node metastases and the positivity for both HSP60 and HSP10. In particular, metastatic lymph nodes show a higher percentage of cells positive for both HSP60 and HSP10 in the secondary follicles, and for HSP10 in the medullary sinuses, when compared with hyperplastic lymph nodes. CONCLUSION: HSP60 and HSP10 may have diagnostic and prognostic significance in the management of this tumour and their overexpression in tumoral cells may be functionally related to tumoral progression. We hypothesise that their expression in follicular and medullary cells of lymph nodes may be induced by formation of metastases. Further studies based on these observations could lead to a better understanding of the HSPs involvement in colorectal cancer progression, as well as other neoplasms. BioMed Central 2005-10-28 /pmc/articles/PMC1289279/ /pubmed/16253146 http://dx.doi.org/10.1186/1471-2407-5-139 Text en Copyright © 2005 Cappello et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cappello, Francesco
David, Sabrina
Rappa, Francesca
Bucchieri, Fabio
Marasà, Lorenzo
Bartolotta, Tommaso E
Farina, Felicia
Zummo, Giovanni
The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase
title The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase
title_full The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase
title_fullStr The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase
title_full_unstemmed The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase
title_short The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase
title_sort expression of hsp60 and hsp10 in large bowel carcinomas with lymph node metastase
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1289279/
https://www.ncbi.nlm.nih.gov/pubmed/16253146
http://dx.doi.org/10.1186/1471-2407-5-139
work_keys_str_mv AT cappellofrancesco theexpressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT davidsabrina theexpressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT rappafrancesca theexpressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT bucchierifabio theexpressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT marasalorenzo theexpressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT bartolottatommasoe theexpressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT farinafelicia theexpressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT zummogiovanni theexpressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT cappellofrancesco expressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT davidsabrina expressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT rappafrancesca expressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT bucchierifabio expressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT marasalorenzo expressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT bartolottatommasoe expressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT farinafelicia expressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase
AT zummogiovanni expressionofhsp60andhsp10inlargebowelcarcinomaswithlymphnodemetastase